FDA Approves Novel Pain Pill Without Addiction Risk

(MedPage Today) — The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.
“Today’s approval is an important…

Source link : https://www.medpagetoday.com/painmanagement/painmanagement/114021

Author :

Publish date : 2025-01-31 14:19:32

Copyright for syndicated content belongs to the linked Source.